Amebic liver abscess with bacterial superinfection in a patient with no epidemiologic risk factors.
The amebic liver abscess is uncommon in developed countries like Spain, but the incidence is increasing probably due to the migratory movements of the population. We report a case of an amebic abscess, initially unsuspected due to the absence of epidemiologic risk factors and the negative serology for amebiasis, in the early stages of the disease.
Sáchez-Pobre
P
P
Department of Medicine, Service of Digestive Diseases, Hospital Universitario 12 de Octubre, Madrid, Spain. psanchezp@meditex.es
Sáenz-López
S
S
Salto
E
E
Sanjuán
R
R
Ibero
C
C
Masedo
A
A
Solís Herruzo
J A
JA
D000818:Animals; D000890:Anti-Infective Agents / Q000627:therapeutic use; D004748:Entamoeba histolytica / Q000187:drug effects / Q000302:isolation & purification*; D015981:Epidemiologic Factors; D006801:Humans; D008099:Liver / Q000469:parasitology; D008101:Liver Abscess, Amebic / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010397:Penicillanic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D010878:Piperacillin / Q000627:therapeutic use; D000077725:Piperacillin, Tazobactam Drug Combination; D012307:Risk Factors; D013030:Spain; D015163:Superinfection / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D000077725:Piperacillin, Tazobactam Drug Combination; D010397:Penicillanic Acid; D010878:Piperacillin